STRATEGIC CHALLENGES IN LATE PHASE DRUG
CONDUCTING POST-APPROVAL STUDIES DEVELOPMENT
DEMONSTRATING VALUE IN LATE PHASE
LATE PHASE CLINICAL TRIAL DESIGN
CHALLENGES IN OUTCOME TRIALS
EMPOWERING PATIENTS AND ENABLING TECHNOLOGIES
OBSERVATIONAL STUDIES AND REAL WORLD SAFETY SURVEILLANCE
COMMUNICATIONS IN PHASE IIIB/IV